• 1
    Harmon WE, Stablein D, Alexander SR, Tejani A. Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1991; 51: 406412.
  • 2
    Singh A, Stablein D, Tejani A. Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1997; 63: 12631267.
  • 3
    McDonald RA, Smith JM, Stablein D, Harmon WE. Pretransplant peritoneal dialysis and graft thrombosis following pediatric kidney transplantation: a NAPRTCS report. Pediatr Transplant 2003; 7: 204208.
  • 4
    McEnery P, Arbus G, Stablein DM, Tejani A. Renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). N Engl J Med 1992; 326: 17271732.
  • 5
    2004 NAPRTCS Annual report.
  • 6
    Vanrenterghem Y, Roels L, Lerut T et al. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1985; 1: 9991002.
  • 7
    Malyszko J, Malyszko JS, Takada A, Mysliwiec M. Effects of immunosuppressive drugs on platelet aggregation in vitro. Ann Transplant 2002; 7: 5568.
  • 8
    Grace AA, Barradas MA, Mikhailidis DP et al. Cyclosporine A enhances platelet aggregation. Kidney Int 1987; 32: 889895.
  • 9
    Neild GH, Ivory K, Williams DG. Glomerular thrombi and infarction in rabbits with serum sickness following cyclosporine therapy. Transplant Proc 1983; 27822783.
  • 10
    Neild GH, Rocchi G, Imberti L, Remuzzi F. Effect of cyclosporine on prostacyclin synthesis by vascular tissue in rabbits. Transplant Proc 1983; 23982399.
  • 11
    Rigotti P, Flechner SM, Van Buren CT, Payne WT, Kahan BD. Increased incidence of renal allograft thrombosis under cyclosporine immunosuppression. Int Surg 1986; 71: 3841.
  • 12
    Laupacis A. Complications of cyclosporine therapy. Transplant Proc 1983; 27482749.
  • 13
    Merion RM, Calne RY. Allograft renal vein thrombosis. Transplant Proc 1985; 17: 17461750.
  • 14
    Louridas G. Botha JR, Meyers A, Myburgh JA. Vascular complications in renal transplantation. Clin Transplant 1987; 240244.
  • 15
    Gruber SA, Chavers B, Payne WD et al. Allograft renal vascular thrombosis—lack of increase with cyclosporine immunosuppression. Transplantation 1989; 47: 475478.
  • 16
    Gruber SA, Pescovitz M, Simmons RL et al. Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin. Transplant Proc 1987; 19: 18151816.
  • 17
    Abramowicz D, Pradier O, Marchant A et al. Induction of thromboses within renal grafts by high-dose prophylactic OKT3. Lancet 1992; 339: 777778.
  • 18
    Bartosh SM, Aronson AJ, Swanson-Pewitt EE, Thistlethwaite JR Jr. OKT3 induction in pediatric renal transplantation. Pediatr Nephrol 1993; 7: 4549.
  • 19
    Abramowicz D, De Pauw L, Le Moine A et al. Prevention of OKT3 nephrotoxicity after kidney transplantation. Kidney Int Suppl 1996; 53: S39S43.
  • 20
    Deira J, Alberca I, Lerma JL, Martin B, Tabernero JM. Changes in coagulation and fibrinolysis in the postoperative period immediately after kidney transplantation in patients receiving OKT3 or cyclosporine A as induction therapy. Am J Kidney Dis 1998; 32: 575581.
  • 21
    Edwards MJ, Miller FN, Sims DE, Abney DL, Schuschke DA, Corey TS. Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage. Cancer Res 1992; 52: 34253431.
  • 22
    Oleksowicz L, Zuckerman D, Mrowiec Z, Puszkin E, Dutcher JP. Effects of interleukin-2 administration on platelet function in cancer patients. Am J Hematol 1994; 45: 224231.
  • 23
    Cotran RS, Pober JS, Gimbrone MA Jr et al. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. J Immunol 1988; 140: 18831888.